GCI Europe 2019
GCI Europe 2019
Register your interest for early-bird spots at GCI Europe 2020

GCI Europe 2019

Took place - November, 2019

Where global leaders shape future cannabis strategies in Europe

ABOUT THE EVENT

GCI Europe brings together leaders, like you, at the forefront of cannabis. Our unique format enables you to customise an agenda, specific to your needs - you’ll be able to develop strong relationships with leaders across the value-chain, including: policy makers; researchers; LPs; CBD brands; retailers; distributors; labs; clinicians; scientists; service providers; and investors.
The home of networking for innovators at the heart of the European Cannabis Market




GCI Europe hosts two co-located conferences as well as interactive breakout streams
 
Disruptive forces are changing the world as we know it for the better, presenting a plethora of opportunities for innovators who like to push the boundaries. Of course, the European cannabis infrastructure is still developing, and as such, provides a multitude of cross-border regulatory challenges that we’re all facing daily. But with challenges, come opportunities.
 



Medicine, Research & Science


Bringing together the greatest minds in the space - researchers, clinicians, academics and pharma leaders come together from institutions globally to discuss the future of medical cannabis and cannabis derived treatment. All focused on the same goal, our experts shared exclusive insights and groundbreaking developments with the GCI Community.
 



Winning Business Strategies


Retailers and distributors can’t get enough of CBD products, however to conquer the European markets much more need be considered. From product launches to marketing & branding, navigating regulations to remaining compliant, our leaders uncovered key strategies to future-proof their growth in Europe from our faculty of industry specialists.
 



Interactive Breakout Streams
 
Dedicated streams focus on Key Canna Economies in Europe, Ancillary Services and Cannabis & Hemp Cultivation. Our leaders learned about the current and future regulatory, political, medical, investment and cultural landscape of 6 key countries (as told by expert Conversation Leaders from each region) and discovered the best strategies to optimize their cultivation operation to service the European Markets.
 

GCI Europe 2019 - Sponsors

Gold Sponsor
Wundr Co.
Brains Bioceutical
Silver Sponsors
CannaPowder
Mile High Labs
Bronze Sponsor
Advanced Dynamics
G4Si
New Frontier Data
EMMAC
Perry Johnson Laboratory Accreditation
Event Partners
Brink's
CannRx
Bedrocan B.V.
Bloom Distribution
CannaX
LIO Pharmaceuticals
Rapid Dose Therapeutics
Toniqly Group Ltd.
Media Partners
Copybook
The Cannabis Scientist
Dosage
Infuzes
Hemp Events
Health Europe
Cannabis Trades Association
CBD-Intel
Krautinvest
Cubid CBD
https://www.wundrco.com/
Wundr is a European cannabis company dedicated to patient access. Our core operation is in Germany, where we supply our own branded flower products.
https://canna-powder.com
The first cannabis activated nanometric powder derived from cannabis oil, making cannabis available to a broader market by increasing the number of delivery options for producers and consumers. The technology was developed at The Hebrew University of Jerusalem by Dr. Shlomo Magdassi, a world leader in R&D of medical cannabis.
https://milehighlabs.com/
Mile High Labs is setting the standards for cannabidiol (CBD) ingredient manufacturing. Our scientifically advanced proprietary process some of the purest CBD available while supplying a considerable portion of the world’s overall market. Mile High’s industrial-scale laboratories and private labelling services are trusted by global partners who understand that compliance, consistency and quality are critical to success.
https://www.brinks.com/en/
The Brink’s Company (NYSE:BCO) is a global leader in high-value logistics, cash management and payments services. We deliver sophisticated, secure, tailored logistics and cash management services to the cannabis industry, from seed to sale, in select locations where the industry has been legalized. With operations in 40+ countries and 62,000 employees, we have a proven history of building customized supply chains for highly regulated and diverse industries, and a global network of expertise, infrastructure and certified partner programs.
https://cannax.io/
CannaX is a community of cannabis professionals, users, enthusiasts and event organizers who share love and passion for cannabis. As a technology company, we provide data processing, app development services and analytics to cannabis event organizers.
https://www.liopharmaceuticals.com/en/home-en/
LIO Pharmaceuticals GmbH combines long-standing experience in the European pharmaceutical market with the vision of an innovative start-up company. 
Specialized in the import and distribution of high quality cannabis materials, LIO is committed to support the medical care and therefore improve the quality of life of patients. From Mission & Vision, through Product, to Market Access, all the way to Sales & Marketing, the Experience always meets innovation Spirit. 

As an interdisciplinary team led by founder and CEO Alain Menghé à Menghé, LIO Pharmaceuticals relies both internally and externally on modern corporate communications, flat hierarchies and an open work environment. 

LIO Pharmaceuticals...Experience driven, Patient focus.
http://www.cubidcbd.com
THE CANNAVIST is the UK’s first dedicated lifestyle CBD publication. Formerly Vapouround CBD, this is the latest publication from Vapouround Magazine, the leading publisher in the global vape trade. Vapouround Magazine began as a B2B publication in 2015. Now in its fourth year, the Vapouround name has evolved to become the global leader in publishing in the e-cigarette industry worldwide with a UK and Ireland flagship publication plus Spanish publications and bespoke show guides.
Global Cannabis Institute
X
Privacy policy and how we use cookies
We use cookies to give you the best experience on our website.
By continuing we'll assume you're on board with our privacy policy
Accept and hide this message